Immune T cells are present in adipose tissues (AT), and the stoichiometry of the different T cell subsets is altered during diet-induced obesity (DIO). T cells contribute to the early steps of AT inflammation during DIO.
Recent Advances:
Many factors could potentially be responsible for this altered pro-inflammatory versus anti-inflammatory T cell balance.
Critical Issues:
T cells are potentially activated in AT, which vitamin D might contribute to, as will be discussed in this article. In addition, we will review the different possible contributors to T cell activation in AT, such as the CD28 and CD154 T cell costimulatory molecules in AT.
Future Directions:
The potential antigen presentation capacities of adipocytes should be further investigated. Moreover, the properties of these AT resident (or migrating to AT) T cells must be further assessed. Antioxid. Redox Signal. 26, 489–500.
Get full access to this article
View all access options for this article.
References
1.
AukrustP, MullerF, UelandT, BergetT, AaserE, BrunsvigA, SolumNO, ForfangK, FrolandSS, and GullestadL. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation, 100: 614–620, 1999.
2.
BaekeF, KorfH, OverberghL, van EttenE, VerstuyfA, GysemansC, and MathieuC. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol, 121: 221–227, 2010.
3.
BaekeF, TakiishiT, KorfH, GysemansC, and MathieuC. Vitamin D: modulator of the immune system. Curr Opin Pharmacol, 10: 482–496, 2010.
4.
BapatSP, Myoung SuhJ, FangS, LiuS, ZhangY, ChengA, ZhouC, LiangY, LeBlancM, LiddleC, AtkinsAR, YuRT, DownesM, EvansRM, and ZhengY. Depletion of fat-resident T cells prevents age-associated insulin resistance. Nature, 528: 137–141, 2015.
5.
BertolaA, CiucciT, RousseauD, BourlierV, DuffautC, BonnafousS, Blin-WakkachC, AntyR, IannelliA, GugenheimJ, TranA, BouloumieA, GualP, and WakkachA. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes, 61: 2238–2247, 2012.
6.
BikleDD, GeeE, and PillaiS. Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol, 101: 713–718, 1993.
7.
BoomerJS and GreenJM. An enigmatic tail of CD28 signaling. Cold Spring Harb Perspect Biol, 2: a002436, 2010.
8.
BouillonR, CarmelietG, VerlindenL, van EttenE, VerstuyfA, LudererHF, LiebenL, MathieuC, and DemayM. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev, 29: 726–776, 2008.
9.
CabezaN, LiZ, SchulzC, KremmerE, MassbergS, BultmannA, and GawazM. Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes, 53: 2117–2121, 2004.
10.
CarlbergC and SeuterS. A genomic perspective on vitamin D signaling. Anticancer Res, 29: 3485–3493, 2009.
11.
ChattopadhyayPK, GierahnTM, RoedererM, and LoveJC. Single-cell technologies for monitoring immune systems. Nat Immunol, 15: 128–135, 2014.
12.
ChatzigeorgiouA, ChungKJ, Garcia-MartinR, AlexakiVI, Klotzsche-von AmelnA, PhielerJ, SprottD, KanczkowskiW, TzanavariT, BdeirM, BergmannS, CartellieriM, BachmannM, NikolakopoulouP, Androutsellis-TheotokisA, SiegertG, BornsteinSR, MudersMH, BoonL, KaralisKP, LutgensE, and ChavakisT. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology, 60: 1196–1210, 2014.
13.
ChatzigeorgiouA, KaralisKP, BornsteinSR, and ChavakisT. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia, 55: 2583–2592, 2012.
14.
ChatzigeorgiouA, SeijkensT, ZarzyckaB, EngelD, PoggiM, van den BergS, SoehnleinO, WinkelsH, BeckersL, LievensD, DriessenA, KustersP, BiessenE, Garcia-MartinR, Klotzsche-von AmelnA, GijbelsM, NoelleR, BoonL, HackengT, SchulteKM, XuA, VriendG, NabuursS, ChungKJ, Willems van DijkK, RensenPC, GerdesN, de WintherM, BlockNL, SchallyAV, WeberC, BornsteinSR, NicolaesG, ChavakisT, and LutgensE. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc Natl Acad Sci U S A, 111: 2686–2691, 2014.
15.
ChoKW, MorrisDL, DelPropostoJL, GeletkaL, ZamarronB, Martinez-SantibanezG, MeyerKA, SingerK, O'RourkeRW, and LumengCN. An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation. Cell Rep, 9: 605–617, 2014.
16.
CipollettaD, FeuererM, LiA, KameiN, LeeJ, ShoelsonSE, BenoistC, and MathisD. PPAR-[ggr] is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature, 486: 549–553, 2012.
17.
CipollettaD, KolodinD, BenoistC, and MathisD. Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin Immunol, 23: 431–437, 2011.
18.
CipolloneF, ChiarelliF, DaviG, FerriC, DesideriG, FaziaM, IezziA, SantilliF, PiniB, CuccurulloC, TuminiS, Del PonteA, SantucciA, CuccurulloF, and MezzettiA. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia, 48: 1216–1224, 2005.
19.
ClarkRB, Bishop-BaileyD, Estrada-HernandezT, HlaT, PuddingtonL, and PadulaSJ. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol, 164: 1364–1371, 2000.
20.
CurtisJM, GrimsrudPA, WrightWS, XuX, FonceaRE, GrahamDW, BrestoffJR, WiczerBM, IlkayevaO, CianfloneK, MuoioDE, ArriagaEA, and BernlohrDA. Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes, 59: 1132–1142, 2010.
21.
DalmasE, ClementK, and Guerre-MilloM. Defining macrophage phenotype and function in adipose tissue. Trends Immunol, 32: 307–314, 2011.
22.
DalmasE, VenteclefN, CaerC, PoitouC, CremerI, Aron-WisnewskyJ, Lacroix-DesmazesS, BayryJ, KaveriSV, ClementK, AndreS, and Guerre-MilloM. T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes, 63: 1966–1977, 2014.
23.
DamoucheA, LazureT, Avettand-FenoelV, HuotN, Dejucq-RainsfordN, SatieAP, MelardA, DavidL, GommetC, GhosnJ, NoelN, PourcherG, MartinezV, BenoistS, BereziatV, CosmaA, FavierB, VaslinB, RouziouxC, CapeauJ, Muller-TrutwinM, Dereuddre-BosquetN, Le GrandR, LambotteO, and BourgeoisC. Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PLoS Pathog, 11: e1005153, 2015.
24.
De RosaV, GalganiM, SantopaoloM, ColamatteoA, LaccettiR, and MatareseG. Nutritional control of immunity: balancing the metabolic requirements with an appropriate immune function. Semin Immunol, 27: 300–309, 2015.
25.
De RosaV, ProcacciniC, CaliG, PirozziG, FontanaS, ZappacostaS, La CavaA, and MatareseG. A key role of leptin in the control of regulatory T cell proliferation. Immunity, 26: 241–255, 2007.
26.
DengT, LyonCJ, MinzeLJ, LinJ, ZouJ, LiuJZ, RenY, YinZ, HamiltonDJ, ReardonPR, ShermanV, WangHY, PhillipsKJ, WebbP, WongSTC, WangR-F, and HsuehWA. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab, 17: 411–422, 2013.
27.
DesideriG and FerriC. Effects of obesity and weight loss on soluble CD40L levels. JAMA, 289: 1781–1782, 2003.
28.
DiSpiritoJR and MathisD. Immunological contributions to adipose tissue homeostasis. Semin Immunol, 27: 315–321, 2015.
DoedensAL, PhanAT, StradnerMH, FujimotoJK, NguyenJV, YangE, JohnsonRS, and GoldrathAW. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol, 14: 1173–1182, 2013.
31.
DuffautC, Zakaroff-GirardA, BourlierV, DecaunesP, MaumusM, ChiotassoP, SengenesC, LafontanM, GalitzkyJ, and BouloumieA. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol, 29: 1608–1614, 2009.
32.
EngelD, SeijkensT, PoggiM, SanatiM, ThevissenL, BeckersL, WijnandsE, LievensD, and LutgensE. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis. Semin Immunol, 21: 308–312, 2009.
33.
FabbriniE, CellaM, McCartneySA, FuchsA, AbumradNA, PietkaTA, ChenZ, FinckBN, HanDH, MagkosF, ConteC, BradleyD, FraterrigoG, EagonJC, PattersonBW, ColonnaM, and KleinS. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology, 145: 366–374 e1–e3, 2013.
34.
FeuererM, HerreroL, CipollettaD, NaazA, WongJ, NayerA, LeeJ, GoldfineAB, BenoistC, ShoelsonS, and MathisD. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med, 15: 930–939, 2009.
35.
GarconF, GhiottoM, GerardA, YangWC, OliveD, and NunesJA. The SH3 domain of Tec kinase is essential for its targeting to activated CD28 costimulatory molecule. Eur J Immunol, 34: 1972–1980, 2004.
GerrietsVA and MacIverNJ. Role of T cells in malnutrition and obesity. Front Immunol, 5: 379, 2014.
38.
GregorMF and HotamisligilGS. Inflammatory mechanisms in obesity. Annu Rev Immunol, 29: 415–445, 2011.
39.
GriffithJW, SokolCL, and LusterAD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol, 32: 659–702, 2014.
40.
GuoCA, KoganS, AmanoSU, WangM, DagdevirenS, FriedlineRH, AouadiM, KimJK, and CzechMP. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance. Am J Physiol Endocrinol Metab, 304: E951–E963, 2013.
41.
HaffnerS and TaegtmeyerH. Epidemic obesity and the metabolic syndrome. Circulation, 108: 1541–1545, 2003.
42.
HonstettreA, MeghariS, NunesJA, LepidiH, RaoultD, OliveD, and MegeJL. Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immun, 74: 1800–1808, 2006.
43.
IssaLL, LeongGM, and EismanJA. Molecular mechanism of vitamin D receptor action. Inflamm Res, 47: 451–475, 1998.
44.
JoshiS, PantalenaLC, LiuXK, GaffenSL, LiuH, Rohowsky-KochanC, IchiyamaK, YoshimuraA, SteinmanL, ChristakosS, and YoussefS. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol, 31: 3653–3669, 2011.
45.
KarkeniE, MarcotorchinoJ, TourniaireF, AstierJ, PeirettiF, DarmonP, and LandrierJF. Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology, 156: 1782–1793, 2015.
46.
KarlssonEA and BeckMA. The burden of obesity on infectious disease. Exp Biol Med, 235: 1412–1424, 2010.
47.
KesarwaniP, MuraliAK, Al-KhamiAA, and MehrotraS. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal, 18: 1497–1534, 2013.
48.
KhanIM, Dai PerrardXY, PerrardJL, MansooriA, SmithCW, WuH, and BallantyneCM. Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency. Atherosclerosis, 233: 419–428, 2014.
49.
KleinD, TimoneriF, IchiiH, RicordiC, and PastoriRL. CD40 activation in human pancreatic islets and ductal cells. Diabetologia, 51: 1853–1861, 2008.
LandrierJF, KarkeniE, MarcotorchinoJ, BonnetL, and TourniaireF. Vitamin D modulates adipose tissue biology: possible consequences for obesity?. Proc Nutr Soc, 75: 38–46, 2016.
52.
LandrierJF, MarcotorchinoJ, and TourniaireF. Lipophilic micronutrients and adipose tissue biology. Nutrients, 4: 1622–1649, 2012.
53.
LeeJH, EllyC, ParkY, and LiuYC. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1alpha to maintain regulatory T cell stability and suppressive capacity. Immunity, 42: 1062–1074, 2015.
54.
LemireJM, AdamsJS, Kermani-ArabV, BakkeAC, SakaiR, and JordanSC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol, 134: 3032–3035, 1985.
55.
LenschowDJ, WalunasTL, and BluestoneJA. CD28/B7 system of T cell costimulation. Annu Rev Immunol, 14: 233–258, 1996.
56.
LifshitzF and LifshitzJZ. Globesity: the root causes of the obesity epidemic in the USA and now worldwide. Pediatr Endocrinol Rev, 12: 17–34, 2014.
57.
LimHS, BlannAD, and LipGY. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation, 109: 2524–2528, 2004.
58.
LordGM, MatareseG, HowardJK, BakerRJ, BloomSR, and LechlerRI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature, 394: 897–901, 1998.
59.
MissiouA, WolfD, PlatzerI, ErnstS, WalterC, RudolfP, ZirlikK, KostlinN, WilleckeFK, MunkelC, SchonbeckU, LibbyP, BodeC, VaroN, and ZirlikA. CD40L induces inflammation and adipogenesis in adipose cells—a potential link between metabolic and cardiovascular disease. Thromb Haemost, 103: 788–796, 2010.
60.
MontesVN, TurnerMS, SubramanianS, DingY, Hayden-LedbetterM, SlaterS, GoodspeedL, WangS, OmerM, Den HartighLJ, AverillMM, O'BrienKD, LedbetterJ, and ChaitA. T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS One, 8: e67709, 2013.
61.
MorinSO, GirouxV, FavreC, BechahY, Auphan-AnezinN, RoncagalliR, MegeJL, OliveD, MalissenM, and NunesJA. In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation. Cell Mol Life Sci, 72: 2739–2748, 2015.
NishimuraS, ManabeI, NagasakiM, EtoK, YamashitaH, OhsugiM, OtsuM, HaraK, UekiK, SugiuraS, YoshimuraK, KadowakiT, and NagaiR. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med, 15: 914–920, 2009.
64.
OgawaS, WatanabeM, SakuraiY, InutakeY, WatanabeS, TaiX, and AbeR. CD28 signaling in primary CD4(+) T cells: identification of both tyrosine phosphorylation-dependent and phosphorylation-independent pathways. Int Immunol, 25: 671–681, 2013.
65.
OsbornO and OlefskyJM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med, 18: 363–374, 2012.
66.
PlumLA and DeLucaHF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov, 9: 941–955, 2010.
67.
PoggiM, EngelD, ChristA, BeckersL, WijnandsE, BoonL, DriessenA, CleutjensJ, WeberC, GerdesN, and LutgensE. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscler Thromb Vasc Biol, 31: 2251–2260, 2011.
68.
PoggiM, JagerJ, Paulmyer-LacroixO, PeirettiF, GremeauxT, VerdierM, GrinoM, StepanianA, MsikaS, BurcelinR, de ProstD, TantiJF, and AlessiMC. The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia, 52: 1152–1163, 2009.
69.
PoggiM, MorinSO, BastelicaD, GoversR, CanaultM, BernotD, GeorgelinO, VerdierM, BurcelinR, OliveD, AlessiMC, PeirettiF, and NunesJA. CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice. Int J Obes (Lond), 39: 977–985, 2015.
70.
PostowMA, ChesneyJ, PavlickAC, RobertC, GrossmannK, McDermottD, LinetteGP, MeyerN, GiguereJK, AgarwalaSS, ShaheenM, ErnstoffMS, MinorD, SalamaAK, TaylorM, OttPA, RollinLM, HorakC, GagnierP, WolchokJD, and HodiFS. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med, 372: 2006–2017, 2015.
71.
PrietlB, TreiberG, PieberTR, and AmreinK. Vitamin D and immune function. Nutrients, 5: 2502–2521, 2013.
72.
ProcacciniC, De RosaV, GalganiM, AbanniL, CaliG, PorcelliniA, CarboneF, FontanaS, HorvathTL, La CavaA, and MatareseG. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity, 33: 929–941, 2010.
73.
ProcacciniC, De RosaV, GalganiM, CarboneF, La RoccaC, FormisanoL, and MatareseG. Role of adipokines signaling in the modulation of T cells function. Front Immunol, 4: 332, 2013.
74.
ProvvediniDM, TsoukasCD, DeftosLJ, and ManolagasSC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science, 221: 1181–1183, 1983.
75.
RauschME, WeisbergS, VardhanaP, and TortorielloDV. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes, 32: 451–463, 2008.
76.
RenehanAG, ZwahlenM, and EggerM. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer, 15: 484–498, 2015.
77.
RochaVZ, FolcoEJ, SukhovaG, ShimizuK, GotsmanI, VernonAH, and LibbyP. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res, 103: 467–476, 2008.
78.
RuhlR and LandrierJF. Dietary regulation of adiponectin by direct and indirect lipid-activators of nuclear hormone receptors. Mol Nutr Food Res, 60: 175–184, 2016.
79.
SantilliF, BasiliS, FerroniP, and DaviG. CD40/CD40L system and vascular disease. Intern Emerg Med, 2: 256–268, 2007.
80.
SchonbeckU and LibbyP. CD40 signaling and plaque instability. Circ Res, 89: 1092–1103, 2001.
81.
SchonbeckU and LibbyP. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci, 58: 4–43, 2001.
82.
SeijkensT, KustersP, ChatzigeorgiouA, ChavakisT, and LutgensE. Immune cell crosstalk in obesity: a key role for costimulation?. Diabetes, 63: 3982–3991, 2014.
83.
SellH, HabichC, and EckelJ. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol, 8: 709–716, 2012.
84.
ShahinianA, PfefferK, LeeKP, KundigTM, KishiharaK, WakehamA, KawaiK, OhashiPS, ThompsonCB, and MakTW. Differential T cell costimulatory requirements in CD28-deficient mice. Science, 261: 609–612, 1993.
TaiX, CowanM, FeigenbaumL, and SingerA. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol, 6: 152–162, 2005.
87.
TourniaireF, Romier-CrouzetB, LeeJH, MarcotorchinoJ, GourantonE, SallesJ, MalezetC, AstierJ, DarmonP, BlouinE, WalrandS, YeJ, and LandrierJF. Chemokine expression in inflamed adipose tissue is mainly mediated by NF-kappaB. PLoS One, 8: e66515, 2013.
88.
VaroN, VicentD, LibbyP, NuzzoR, Calle-PascualAL, BernalMR, Fernandez-CruzA, VevesA, JarolimP, VaroJJ, GoldfineA, HortonE, and SchonbeckU. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation, 107: 2664–2669, 2003.
89.
VersiniM, JeandelPY, RosenthalE, and ShoenfeldY. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev, 13: 981–1000, 2014.
90.
VujicicM, NikolicI, KontogianniVG, SaksidaT, CharisiadisP, Orescanin-DusicZ, BlagojevicD, Stosic-GrujicicS, TzakosAG, and StojanovicI. Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity. Br J Nutr, 113: 770–782, 2015.
91.
WangS, BaidooSE, LiuY, ZhuC, TianJ, MaJ, TongJ, ChenJ, TangX, XuH, and LuL. T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis. Clin Exp Immunol, 171: 63–68, 2013.
92.
WeisbergSP, McCannD, DesaiM, RosenbaumM, LeibelRL, and FerranteAWJr.Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 112: 1796–1808, 2003.
93.
WinerS, ChanY, PaltserG, TruongD, TsuiH, BahramiJ, DorfmanR, WangY, ZielenskiJ, MastronardiF, MaezawaY, DruckerDJ, EnglemanE, WinerD, and DoschHM. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med, 15: 921–929, 2009.
94.
WolfD, JehleF, MichelNA, BukoszaEN, RiveraJ, ChenYC, HoppeN, DufnerB, RodriguezAO, ColbergC, NietoL, RupprechtB, WiedemannA, SchulteL, PeikertA, BasslerN, LozhkinA, HergethSP, StachonP, HilgendorfI, WilleckeF, von Zur MuhlenC, von ElverfeldtD, BinderCJ, AicheleP, VaroN, FebbraioMA, LibbyP, BodeC, PeterK, and ZirlikA. Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice. Circulation, 129: 2414–2425, 2014.
95.
XiaoL, YangX, LinY, LiS, JiangJ, QianS, TangQ, HeR, and LiX. Large adipocytes function as antigen-presenting cells to activate CD4 T cells via upregulating MHCII in obesity. Int J Obes, 40: 112–120, 2016.
96.
XuH, BarnesGT, YangQ, TanG, YangD, ChouCJ, SoleJ, NicholsA, RossJS, TartagliaLA, and ChenH. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest, 112: 1821–1830, 2003.
97.
YuY, LiuY, ShiFD, ZouH, MatareseG, and La CavaA. Cutting edge: leptin-induced RORgammat expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol, 190: 3054–3058, 2013.
98.
ZengH and ChiH. Metabolic control of regulatory T cell development and function. Trends Immunol, 36: 3–12, 2015.
